Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden · Delayed Price · Currency is SEK 0.0030
-0.0002 (-6.25%)
Apr 24, 2026, 5:04 PM CET
STO:LPGO Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
1.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 10.29M | -6.12M | -37.30% |
| Dec 31, 2023 | 16.41M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 2.21M | -1.80M | -44.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fluicell AB | 15.22M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| AcouSort AB | 10.43M |
| Aptahem AB | 2.59M |
| Biosergen AB | 2.09M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| NanoEcho AB | 487.00K |